• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
  LongeCity
              Advocacy & Research for Unlimited Lifespans
  • .org
  • Districts
  • Media
  • SupportUs
  • Collaborate
  • Contact
  • Search
  • Join


Adverts help to support the work of this non-profit organisation. To go ad-free join as a Member.


Photo

BioTime Inc.

Started by caliban , Mar 25 2011 01:11 AM
economics regenerative medicine stemells tissue engineering regmed

  • Please log in to reply
777 replies to this topic

#721 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 30 July 2016 - 04:30 PM

Shares Trending Upward for the Week: BioTime, Inc. (:BTX)
Engelwood Daily - 1 hour ago
Investors BioTime, Inc. (:BTX) are heading into the weekend on a positive note as the stock provided some gains this week moving 4.00% over the past 5 trading days.

View the full article

#722 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 30 July 2016 - 04:30 PM

Shares Trending Upward for the Week: BioTime, Inc. (:BTX)
Engelwood Daily - 8 hours ago
Investors BioTime, Inc. (:BTX) are heading into the weekend on a positive note as the stock provided some gains this week moving 4.00% over the past 5 trading days.

View the full article

#723 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 30 July 2016 - 04:30 PM

Shares Trending Upward for the Week: BioTime, Inc. (:BTX)
Engelwood Daily - 15 hours ago
Investors BioTime, Inc. (:BTX) are heading into the weekend on a positive note as the stock provided some gains this week moving 4.00% over the past 5 trading days.

View the full article

sponsored ad

  • Advert

#724 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 30 July 2016 - 04:30 PM

Shares Trending Upward for the Week: BioTime, Inc. (:BTX)
Engelwood Daily - Jul 30, 2016
Investors BioTime, Inc. (:BTX) are heading into the weekend on a positive note as the stock provided some gains this week moving 4.00% over the past 5 trading days.

View the full article

#725 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 07 August 2016 - 07:41 AM

EPS for BioTime, Inc. (BTX) Expected to Increase
Consumer Eagle - 7 hours ago
Wall Street await BioTime, Inc. (NYSEMKT:BTX) to release earnings on August, 8. Analysts forecast EPS of $-0.17, down exactly $0.05 or 41.67% from 2014's $-0.12 EPS.

View the full article

#726 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 07 August 2016 - 04:30 PM

Stock Showing Gains for the Week: BioTime, Inc. (:BTX)
Engelwood Daily - 2 hours ago
Investors BioTime, Inc. (:BTX) are heading into the weekend on a positive note as the stock provided some gains this week moving 0.95% over the past 5 trading days.

View the full article

#727 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 07 August 2016 - 04:30 PM

Stock Showing Gains for the Week: BioTime, Inc. (:BTX)
Engelwood Daily - 12 hours ago
Investors BioTime, Inc. (:BTX) are heading into the weekend on a positive note as the stock provided some gains this week moving 0.95% over the past 5 trading days.

View the full article

#728 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 08 August 2016 - 12:45 PM

BioTime Inc. (BTX) Scheduled to Post Earnings on Tuesday
Community Financial News - 6 hours ago
BioTime (NYSEMKT:BTX) last released its quarterly earnings data on Tuesday, May 10th. The company reported ($0.19) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.14) by $0.05.

View the full article

#729 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 09 August 2016 - 05:15 PM

Is Selling Stock Like BioTime, Inc. After Such Decline Winning Strategy?
Press Telegraph - 2 hours ago
The stock of BioTime, Inc. (NYSEMKT:BTX) is a huge mover today! About 163,688 shares traded hands. BioTime, Inc. (NYSEMKT:BTX) has declined 9.78% since January 4, 2016 and is downtrending. It has underperformed by 18.14% the S&P500. The move ...

View the full article

#730 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 09 August 2016 - 08:48 PM

BioTime Inc. (BTX) Posts Quarterly Earnings Results
Community Financial News - 2 hours ago
BioTime logo BioTime Inc. (NYSEMKT:BTX) announced its earnings results on Tuesday. The company reported $0.26 earnings per share for the quarter.
Is Selling Stock Like BioTime, Inc. After Such Decline Winning Strategy? - Press Telegraph

View the full article

#731 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 09 August 2016 - 08:15 PM

BioTime, Inc. Reports Second Quarter Results and Recent Corporate Accomplishments
Business Wire (press release) - 2 hours ago
BUSINESS WIRE)--BioTime, Inc. (NYSE MKT:BTX), a clinical-stage regenerative medicine company with a focus on pluripotent stem cell technology, today reported financial results for the second quarter ended June 30, 2016 and provided a corporate update ...

View the full article

#732 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 25 July 2016 - 05:26 PM

BRIEF-Biotime Inc Reports second quarter results and recent corporate ...
Reuters - Jul 25, 2016
BRIEF-Biotime Inc Reports second quarter results and recent corporate accomplishments. Aug 9 Biotime Inc. * Q2 revenue $1.3 million versus $2.0 million.

View the full article

#733 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 09 August 2016 - 09:42 PM

BRIEF-Biotime Inc Reports second quarter results and recent corporate ...
Reuters - 22 hours ago
Aug 9 Biotime Inc. * Q2 revenue $1.3 million versus $2.0 million. * Biotime, Inc. Reports second quarter results and recent corporate accomplishments.

View the full article

#734 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 11 August 2016 - 10:48 AM

BioTime, Inc. (BTX) Updated Price Targets
FTSE News - 2 hours ago
02/19/2016 - Chardan Capital began new coverage on BioTime, Inc. giving the company a “buy” rating. They now have a USD 5 price target on the stock.

View the full article

#735 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 12 August 2016 - 09:56 PM

BioTime Inc. (BTX) Stock Rating Upgraded by Zacks Investment Research
The Cerbat Gem - 2 hours ago
BioTime logo BioTime Inc. (NYSEMKT:BTX) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued on Friday.

View the full article

#736 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 15 August 2016 - 11:37 AM

Worth Watching Stocks: American Shared Hospital Services (NYSE:AMS), BioTime ...
Benchmark Monitor - 4 hours ago
American Shared Hospital Services (NYSE:AMS) traded 48749 shares on last trading day with closing price of $2.25. Company gross margin stands at 41.10% whereas its return on investment (ROI) is -1.40%.

View the full article

#737 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 15 August 2016 - 11:37 AM

Worth Watching Stocks: American Shared Hospital Services (NYSE:AMS), BioTime ...
Benchmark Monitor - 7 hours ago
American Shared Hospital Services (NYSE:AMS) traded 48749 shares on last trading day with closing price of $2.25. Company gross margin stands at 41.10% whereas its return on investment (ROI) is -1.40%.

View the full article

#738 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 16 August 2016 - 04:30 AM

Insiders Have Increased Positions in: BioTime, Inc. (:BTX)
Engelwood Daily - 1 hour ago
According to the latest SEC filings, insiders at BioTime, Inc. (:BTX) have increased their position in the stock by 9.19% over the past 6 months.

View the full article

#739 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 02 June 2017 - 08:37 PM

Zacks Investment Research Lowers BioTime, Inc. (BTX) to Hold
Sports Perspectives - 2 hours ago
BioTime logo BioTime, Inc. (NYSEMKT:BTX) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued to investors on Tuesday, May 23rd.
BioTime, Inc. (:BTX) Runs -3.98% For the Week - Concord Register

View the full article

#740 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 08 June 2017 - 08:03 PM

BioTime to Announce Top Line Data From the Company's Renevia European Pivotal ...
Business Wire (press release) - 2 hours ago
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX), a clinical-stage biotechnology company developing and commercializing products addressing degenerative diseases, today announced that it will report the top line data from the ...

View the full article

#741 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 19 July 2017 - 10:52 AM

Data From BioTime's Phase I/IIa OpRegen® Trial to be Presented at the 2017 ...
Business Wire (press release) - 52 minutes ago
BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX), a clinical-stage biotechnology company developing and commercializing products addressing degenerative diseases, today announced that an abstract related to the Company's retinal tissue implant has ...

View the full article

#742 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 17 August 2017 - 10:52 AM

AgeX Therapeutics Closes $10 Million Capital Raise
Business Wire (press release) - 2 hours ago
ALAMEDA, Calif.--(BUSINESS WIRE)--AgeX Therapeutics, Inc. (AgeX), a subsidiary of BioTime, Inc. (NYSE American: BTX), announced today that it has closed its round of equity financing, raising net proceeds of $10 million, valuing AgeX at approximately ...
Zacks Investment Research Downgrades BioTime, Inc. (BTX) to Hold - Chaffey Breeze

View the full article

#743 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 28 August 2017 - 10:52 AM

BioTime to Present Data at the Military Health System Research Symposium
Business Wire (press release) - 3 hours ago
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on developing and commercializing products addressing degenerative diseases, today announced that it will be presenting one ...

View the full article

#744 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 14 September 2017 - 09:33 PM

Two Key BioTime Patents Providing Protection to OpRegen® Remain Upheld
Business Wire (press release) - 58 minutes ago
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE American: BTX), a clinical stage biotechnology company focused on developing and commercializing products addressing degenerative diseases, and its subsidiaries, today announced the ...

View the full article

#745 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 14 September 2017 - 08:37 PM

BioTime, Inc. (AMEX:BTX): A Peek Behind the Curtain
Financial Newsweek - 1 hour ago
Taking a look at some historical volatility numbers on shares of BioTime, Inc. (AMEX:BTX), we can see that the 12 month volatility is presently 48.338900.
QI & Technicals in View For BioTime, Inc. (AMEX:BTX) - Pearson Press

View the full article

#746 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 18 September 2017 - 10:52 AM

BioTime Awarded Grant from the NIH
Business Wire (press release) - 3 hours ago
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE American:BTX), a clinical-stage biotechnology company focused on developing and commercializing products addressing degenerative diseases, today announced that it has been awarded a grant ...

View the full article

#747 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 25 September 2017 - 11:26 AM

BRIEF-BioTime board approves distribution of Agex Therapeutics shares
Reuters - 2 hours ago
BRIEF-BioTime board approves distribution of Agex Therapeutics shares. Reuters Staff. 1 Min Read. Sept 25 (Reuters) - BioTime Inc. * BioTime board of directors approves distribution of Agex Therapeutics shares to BioTime shareholders. * BioTime -‍board ...

View the full article

#748 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 26 September 2017 - 11:03 AM

BioTime (BTX) Reports Positive Secondary and Additional Positive Long-Term ...
StreetInsider.com - 3 hours ago
BioTime, Inc. (NYSE: BTX), a clinical-stage biotechnology company focused on developing and commercializing products addressing degenerative diseases, today announced that treated patients from the Renevia® pivotal trial in Europe retained an average ...

View the full article

#749 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 03 October 2017 - 08:15 AM

BioTime to Present at the Cell and Gene Meeting on the Mesa
Business Wire (press release) - 6 hours ago
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on developing and commercializing products addressing degenerative diseases, today announced that Jim Knight, SVP, Head of ...

View the full article

#750 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 10 November 2017 - 02:15 AM

BioTime's (BTX) CEO Michael West on Q3 2017 Results - Earnings Call Transcript
Seeking Alpha - 6 hours ago
Greetings, and welcome to BioTime, Inc. Third Quarter 2017 Earnings Conference Call. [Operator Instructions]. As a reminder, this conference is being recorded.

View the full article
Back to Ventures & Markets



Also tagged with one or more of these keywords: economics, regenerative medicine, stemells, tissue engineering, regmed

1 user(s) are reading this topic

0 members, 0 guests, 0 anonymous users


    Facebook (1)
  1. LONGECITY
  2. → Round Table Discussion
  3. → Business
  4. → Ventures & Markets
  5. site rules